Peripheral blood levels of matrix metalloproteinase-9 predict lesion volume in acute stroke

Neurological Sciences

Volumn 34, Issue 3, 2013, Pages 379-382

  Ulrich, Nils H ^a,b   Dehmel, T ^b   Wittsack, H J ^b   Kieseier, B C ^b   Seitz, R J ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Diffusion weighted imaging; Magnetic resonance imaging; Metalloproteinases; MMP 9; Perfusion weighted imaging; Stroke

Indexed keywords

GELATINASE B; RNA;

ADULT; AGED; ARTICLE; BLOOD; BLOOD SAMPLING; BRAIN INFARCTION; BRAIN INJURY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIFFUSION WEIGHTED IMAGING; ENZYME INHIBITION; FEMALE; HOUSEKEEPING GENE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; ZYMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RNA, MESSENGER; STROKE; UP-REGULATION;

EID: 84879684732     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-012-0999-8     Document Type: Article

References (13)

1. Rosenberg GA, Navratil M, Barone F, Feuerstein G (1996) Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab 16(3):360-366
2. Horstmann S, Kalb P, Koziol J, Gardner H, Wagner S (2003) Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies. Stroke 34(9):2165-2170
3. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC (1998) Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29(5):1020-1030
4. Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, Lo EH (2000) Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 20(12):1681-1689
5. Montaner J, Molina CA, Monasterio J, Abilleira S, Arenillas JF, Ribo M et al (2003) Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 107(4):598-603
6. Neumann-Haefelin T, Wittsack HJ, Wenserski F, Siebler M, Seitz RJ, Modder U et al (1999) Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. Stroke 30(8):1591-1597
7. Wittsack HJ, Ritzl A, Fink GR, Wenserski F, Siebler M, Seitz RJ et al (2002) MR imaging in acute stroke: diffusion-weighted and perfusion imaging parameters for predicting infarct size. Radiology 222(2):397-403
8. Heussen C, Dowdle EB (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102(1):196-202
9. Parks WC, Wilson CL, Lopez-Boado YS (2004) Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4(8):617-629
10. Planas AM, Sole S, Justicia C, Farre ER (2000) Estimation of gelatinase content in rat brain: effect of focal ischemia. Biochem Biophys Res Commun 278(3):803-807
11. Pfefferkorn T, Rosenberg GA (2003) Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion. Stroke 34(8):2025-2030
12. Wang X, Tsuji K, Lee SR, Ning M, Furie KL, Buchan AM et al (2004) Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke 35(11 Suppl 1):2726-2730
13. Tsuji K, Aoki T, Tejima E, Arai K, Lee SR, Atochin DN et al (2005) Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke 36(9):1954-1959